Filed 1mo ago· Apr 7, 2026
29 days to disclose
Gilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Halozyme Therapeutics
HALO
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 9, 2026
Common Stock
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–7 of 7
Filed 1.2y ago· Apr 7, 2025
14 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Halozyme Therapeutics
HALO
$1K-$15K
+2.2% vs S&P 500
Trade dateMar 24, 2025
Common Stock
Filed 1.7y ago· Oct 3, 2024
24 days to disclose
Josh Gottheimer
DHouseNew Jersey-05
↓sold
Halozyme Therapeutics
HALO
$1K-$15K
−4.2% vs S&P 500
Trade dateSep 9, 2024
Common Stock
Filed 2.8y ago· Aug 13, 2023
32 days to disclose
Daniel S. Goldman
DHouseNew York-10
↓sold
Halozyme Therapeutics
HALO
$15K-$50K
+14.5% vs S&P 500
Trade dateJul 12, 2023
Filed 3.4y ago· Jan 13, 2023
38 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Halozyme Therapeutics
HALO
$1K-$15K
+8.1% vs S&P 500
Trade dateDec 6, 2022
Filed 3.7y ago· Sep 16, 2022
42 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Halozyme Therapeutics
HALO
$1K-$15K
+13.0% vs S&P 500
Trade dateAug 5, 2022
Filed 4.7y ago· Sep 20, 2021
31 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Halozyme Therapeutics
HALO
$1K-$15K
+58.4% vs S&P 500
Trade dateAug 20, 2021
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Halozyme Therapeutics HALO Common Stock | Mar 9, 2026 29 days to disclose | Bad buy·−$222-2.8% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Halozyme Therapeutics HALO Common Stock | Mar 24, 2025 14 days to disclose | Flat·+0.0% +2.2% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 3, 2024 1.7y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Halozyme Therapeutics HALO Common Stock | Sep 9, 2024 24 days to disclose | Flat·+0.0% −4.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Halozyme Therapeutics HALO | Jul 12, 2023 32 days to disclose | Flat·+0.0% +14.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 13, 2023 3.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Halozyme Therapeutics HALO | Dec 6, 2022 38 days to disclose | Flat·+0.0% +8.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 16, 2022 3.7y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Halozyme Therapeutics HALO | Aug 5, 2022 42 days to disclose | Flat·+0.0% +13.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 20, 2021 4.7y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Halozyme Therapeutics HALO | Aug 20, 2021 31 days to disclose | Good buy·+$5.4K+67.5% +58.4% vs S&P 500 | $1K-$15K midpoint $8K |